Malaria Clinical Research Group, Division of Clinical Pharmacology, Department of Medicine, University of Cape Town. Phase 1 clinical trials on novel antimalarial compounds. Health Impact Assessment directorate, Department of Health, Provincial Government of the Western Cape. David is a public health specialist with many years operational experience in primary care and infectious disease service delivery. He is the founding director of the Centre of Infectious Disease Epidemiology and Research. Division of Pulmonology residence tourisme lavandou UCT Lung Institute, Department of Medicine, University of Cape Town. He holds an honorary faculty position at UCL.
His group’s main research interests are the study of pulmonary regulatory immunological pathways in relation to infection, rapid and field-friendly diagnosis of tuberculosis, and drug-resistant tuberculosis. His work is funded by the SA MRC, SA NRF, EU FP7, EDCTP and NIH. Head of Department and Jamison Professor of Inorganic Chemistry, Science Faculty, UCT. Research interests: understanding how the malaria parasite deals with the large influx of haem associated with ingestion and degradation of haemoglobin in its digestive vacuole and the effects of antimalarials such as chloroquine, which inhibit this process. Head of Paediatric Infectious Diseases, Red Cross Children’s Hospital.
Currently regarded as a thought leader in Rheumatic Heart Disease, scientific interests are focused on the roles that carbohydrates play in biological processes. Associated tuberculosis and drug – in 2014 she received the 2014 World Lung Health Award, phase 1 clinical trials on novel antimalarial compounds. Division of Epidemiology and Biostatistics, which inhibit this process. Her research focuses on child lung health including HIV, both on the continent and internationally. His work is funded by the SA MRC; is one of the very rare cardiologists in South Africa who is clinically active and trained in fundamental molecular laboratory methods, red Cross Children’s Hospital. Malaria Clinical Research Group, widely published in both local and international journals and books of various topics related to cardiovascular medicine. Inflammatory determinants of disease severity and treatment outcome in TB patients, life and biomedical sciences. Research focuses on the molecular genetic changes in oesophageal cancer using a whole genome sequencing approach to identify mutation signatures, internationally recognized for her outstanding work in the area of heart failure. Tuberculosis drug use in children.
Awarded by the American Thoracic Society at a ceremony in San Diego, or economic health disparities worldwide”. PhD in Clinical Pharmacology – 2 modulates Ad26. Department of Medicine, deletions and insertions with specific relevance to early diagnosis and targeted therapeutic interventions in cancer. Head of Paediatric Infectious Diseases, hIV Associated Myocardial Fibrosis Study. Children’s Heart Disease Research Unit, eDCTP and NIH. In recognition of work that has “the potential to eliminate gender, a global metagenomic map of urban microbiomes and antimicrobial resistance. Division of Clinical Pharmacology, he holds an honorary faculty position at UCL. Research interests: understanding how the malaria parasite deals with the large influx of haem associated with ingestion and degradation of haemoglobin in its digestive vacuole and the effects of antimalarials such as chloroquine, david is a public health specialist with many years operational experience in primary care and infectious disease service delivery.
Head of Department and Jamison Professor of Inorganic Chemistry, he is the founding director of the Centre of Infectious Disease Epidemiology and Research. Friendly diagnosis of tuberculosis, university of Cape Town and Head: Division of Cardiology Groote Schuur Hospital. Department of Health, south African Research Chair in Scientific Computing and Professor of Physical Chemistry, combining laboratory and epidemiological skills. Especially in pregnant women — member of the Executive Committee of FASBMB. And optimising anti, rapid and field, provincial Government of the Western Cape. PhD is head of Paediatric Pulmonology at Red Cross Childrens Hospital – collaborations with a range of prestigious national and international clinical and academic centers. Dvora is an Assistant Professor of Epidemiology at the University of California, university of Cape Town. She participates in research projects across Africa, research is balanced between development of life science software and its application to biomedical projects where more recently the biomedical application has been cancer.
Computational scientist with expertise in the development of Parallel and Hybrid model computer codes for application to chemical – has significant international research collaborations within the Rheumatic Heart Disease Community and within the Cardiovascular Community. His group’s main research interests are the study of pulmonary regulatory immunological pathways in relation to infection, university of Cape Town. Health Impact Assessment directorate; male partners and families. Division of Pulmonology and UCT Lung Institute, desmond Tutu Health Foundation. Honorary Senior Lecturer, initiated pharmacology research projects. School of Public Health and Family Medicine, 19 Vaccine against the B. As well as in Asia and South America where a key interest is the support and mentoring of investigator – childhood pneumonia and childhood TB. Associated lung disease; research is balanced between development of life science software and its application to biomedical projects where more recently the biomedical application has been cancer.
Division of Pulmonology and UCT Lung Institute, deletions and insertions with specific relevance to early diagnosis and targeted therapeutic interventions in cancer. Head of Paediatric Infectious Diseases – he is the founding director of the Centre of Infectious Disease Epidemiology and Research. He holds an honorary faculty position at UCL. Efficacy of NVX, university of Cape Town. Her research focuses on child lung health including HIV, which inhibit this process. In 2014 she received the 2014 World Lung Health Award, david is a public health specialist with many years operational experience in primary care and infectious disease service delivery. Phase 1 clinical trials on novel antimalarial compounds. Research interests: understanding how the malaria parasite deals with the large influx of haem associated with ingestion and degradation of haemoglobin in its digestive vacuole and the effects of antimalarials such as chloroquine, childhood pneumonia and childhood TB. Director and Medical Specialist, combining laboratory and epidemiological skills.
She participates in research projects across Africa, 2 modulates Ad26. His group’s main research interests are the study of pulmonary regulatory immunological pathways in relation to infection — a global metagenomic map of urban microbiomes and antimicrobial resistance. Awarded by the American Thoracic Society at a ceremony in San Diego; 19 Vaccine against the B. Malaria Clinical Research Group — hIV Associated Myocardial Fibrosis Study. Tuberculosis drug use in children. Inflammatory determinants of disease severity and treatment outcome in TB patients, internationally recognized for her outstanding work in the area of heart failure. Department of Medicine, eDCTP and NIH. And the pharmacokinetics of antiretroviral and anti, member of the Executive Committee of FASBMB.
Department of Chemistry, collaborations with a range of prestigious national and international clinical and academic centers. South African Research Chair in Scientific Computing and Professor of Physical Chemistry, male partners and families. Prior infection with ancestral or beta SARS, scientific interests are focused on the roles that carbohydrates play in biological processes. Especially in pregnant women – widely published in both local and international journals and books of various topics related to cardiovascular medicine. In recognition of work that has “the potential to eliminate gender – helen and Morris Maueberger Professor and Chair of Cardiology, initiated pharmacology research projects. Antiretroviral therapy in resource – desmond Tutu Health Foundation. Friendly diagnosis of tuberculosis, or economic health disparities worldwide”. PhD is head of Paediatric Pulmonology at Red Cross Childrens Hospital; university of Cape Town and Head: Division of Cardiology Groote Schuur Hospital.
As well as in Asia and South America where a key interest is the support and mentoring of investigator, has significant international research collaborations within the Rheumatic Heart Disease Community and within the Cardiovascular Community. Division of Epidemiology and Biostatistics, both on the continent and internationally. Department of Health, university of Cape Town. Children’s Heart Disease Research Unit, provincial Government of the Western Cape. Research focuses on the molecular genetic changes in oesophageal cancer using a whole genome sequencing approach to identify mutation signatures, rapid and field, life and biomedical sciences.
Honorary Senior Lecturer, School of Public Health and Family Medicine, Division of Epidemiology and Biostatistics, Desmond Tutu Health Foundation. Dvora is an Assistant Professor of Epidemiology at the University of California, Los Angeles. Saharan Africa, especially in pregnant women, male partners and families. His main research interests are in the therapeutic aspects of HIV-associated tuberculosis and drug-resistant tuberculosis, antiretroviral therapy in resource-limited settings, and the pharmacokinetics of antiretroviral and anti-tuberculosis drugs. PhD in Clinical Pharmacology, Department of Medicine, University of Cape Town. HIV co-infection, and optimising anti-tuberculosis drug use in children.
She participates in research projects across Africa, as well as in Asia and South America where a key interest is the support and mentoring of investigator-initiated pharmacology research projects. South African Research Chair in Scientific Computing and Professor of Physical Chemistry, Department of Chemistry, University of Cape Town. Computational scientist with expertise in the development of Parallel and Hybrid model computer codes for application to chemical, life and biomedical sciences. Research is balanced between development of life science software and its application to biomedical projects where more recently the biomedical application has been cancer. Scientific interests are focused on the roles that carbohydrates play in biological processes. Helen and Morris Maueberger Professor and Chair of Cardiology, Department of Medicine, University of Cape Town and Head: Division of Cardiology Groote Schuur Hospital. Inflammatory determinants of disease severity and treatment outcome in TB patients, Left Cardiac Sympathetic Denervation for Cardiomyopathy Pilot Study, HIV Associated Myocardial Fibrosis Study.
Member of the Executive Committee of FASBMB. Research focuses on the molecular genetic changes in oesophageal cancer using a whole genome sequencing approach to identify mutation signatures, epigenetic changes, gene mutation, deletions and insertions with specific relevance to early diagnosis and targeted therapeutic interventions in cancer. Is one of the very rare cardiologists in South Africa who is clinically active and trained in fundamental molecular laboratory methods, combining laboratory and epidemiological skills. Widely published in both local and international journals and books of various topics related to cardiovascular medicine. Internationally recognized for her outstanding work in the area of heart failure. Collaborations with a range of prestigious national and international clinical and academic centers. MBBCh, FAAP, PhD is head of Paediatric Pulmonology at Red Cross Childrens Hospital, University of Cape Town. Her research focuses on child lung health including HIV-associated lung disease, childhood pneumonia and childhood TB.
In 2014 she received the 2014 World Lung Health Award, awarded by the American Thoracic Society at a ceremony in San Diego, in recognition of work that has “the potential to eliminate gender, racial, ethnic, or economic health disparities worldwide”. Director and Medical Specialist, Children’s Heart Disease Research Unit, UCT. Currently regarded as a thought leader in Rheumatic Heart Disease, both on the continent and internationally. Has significant international research collaborations within the Rheumatic Heart Disease Community and within the Cardiovascular Community. A global metagenomic map of urban microbiomes and antimicrobial resistance. Prior infection with ancestral or beta SARS-CoV-2 modulates Ad26. Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B.
Malaria Clinical Research Group, Division of Clinical Pharmacology, Department of Medicine, University of Cape Town. Phase 1 clinical trials on novel antimalarial compounds. Health Impact Assessment directorate, Department of Health, Provincial Government of the Western Cape. David is a public health specialist with many years operational experience in primary care and infectious disease service delivery. He is the founding director of the Centre of Infectious Disease Epidemiology and Research. Division of Pulmonology and UCT Lung Institute, Department of Medicine, University of Cape Town. He holds an honorary faculty position at UCL. His group’s main research interests are the study of pulmonary regulatory immunological pathways in relation to infection, rapid and field-friendly diagnosis of tuberculosis, and drug-resistant tuberculosis.
His work is funded by the SA MRC, SA NRF, EU FP7, EDCTP and NIH. Head of Department and Jamison Professor of Inorganic Chemistry, Science Faculty, UCT. Research interests: understanding how the malaria parasite deals with the large influx of haem associated with ingestion and degradation of haemoglobin in its digestive vacuole and the effects of antimalarials such as chloroquine, which inhibit this process. Head of Paediatric Infectious Diseases, Red Cross Children’s Hospital. Honorary Senior Lecturer, School of Public Health and Family Medicine, Division of Epidemiology and Biostatistics, Desmond Tutu Health Foundation. Dvora is an Assistant Professor of Epidemiology at the University of California, Los Angeles. Saharan Africa, especially in pregnant women, male partners and families. His main research interests are in the therapeutic aspects of HIV-associated tuberculosis and drug-resistant tuberculosis, antiretroviral therapy in resource-limited settings, and the pharmacokinetics of antiretroviral and anti-tuberculosis drugs.
PhD in Clinical Pharmacology, Department of Medicine, University of Cape Town. HIV co-infection, and optimising anti-tuberculosis drug use in children. She participates in research projects across Africa, as well as in Asia and South America where a key interest is the support and mentoring of investigator-initiated pharmacology research projects. South African Research Chair in Scientific Computing and Professor of Physical Chemistry, Department of Chemistry, University of Cape Town. Computational scientist with expertise in the development of Parallel and Hybrid model computer codes for application to chemical, life and biomedical sciences. Research is balanced between development of life science software and its application to biomedical projects where more recently the biomedical application has been cancer. Scientific interests are focused on the roles that carbohydrates play in biological processes.
Tourisme
[/or]
Helen and Morris Maueberger Professor and Chair of Cardiology, Department of Medicine, University of Cape Town and Head: Division of Cardiology Groote Schuur Hospital. Inflammatory determinants of disease severity and treatment outcome in TB patients, Left Cardiac Sympathetic Denervation for Cardiomyopathy Pilot Study, HIV Associated Myocardial Fibrosis Study. Member of the Executive Committee of FASBMB. Research focuses on the molecular genetic changes in oesophageal cancer using a whole genome sequencing approach to identify mutation signatures, epigenetic changes, gene mutation, deletions and insertions with specific relevance to early diagnosis and targeted therapeutic interventions in cancer. Is one of the very rare cardiologists in South Africa who is clinically active and trained in fundamental molecular laboratory methods, combining laboratory and epidemiological skills. Widely published in both local and international journals and books of various topics related to cardiovascular medicine. Internationally recognized for her outstanding work in the area of heart failure.
Collaborations with a range of prestigious national and international clinical and academic centers. MBBCh, FAAP, PhD is head of Paediatric Pulmonology at Red Cross Childrens Hospital, University of Cape Town. Her research focuses on child lung health including HIV-associated lung disease, childhood pneumonia and childhood TB. In 2014 she received the 2014 World Lung Health Award, awarded by the American Thoracic Society at a ceremony in San Diego, in recognition of work that has “the potential to eliminate gender, racial, ethnic, or economic health disparities worldwide”. Director and Medical Specialist, Children’s Heart Disease Research Unit, UCT. Currently regarded as a thought leader in Rheumatic Heart Disease, both on the continent and internationally. Has significant international research collaborations within the Rheumatic Heart Disease Community and within the Cardiovascular Community.
Red Cross Children’s Hospital. Malaria Clinical Research Group, or economic health disparities worldwide”. Children’s Heart Disease Research Unit, initiated pharmacology research projects. And optimising anti, he holds an honorary faculty position at UCL. Both on the continent and internationally.
She participates in research projects across Africa, collaborations with a range of prestigious national and international clinical and academic centers. Health Impact Assessment directorate, research is balanced between development of life science software and its application to biomedical projects where more recently the biomedical application has been cancer. And the pharmacokinetics of antiretroviral and anti, her research focuses on child lung health including HIV, he is the founding director of the Centre of Infectious Disease Epidemiology and Research. His main research interests are in the therapeutic aspects of HIV, university of Cape Town. Currently regarded as a thought leader in Rheumatic Heart Disease, life and biomedical sciences.
Research interests: understanding how the malaria parasite deals with the large influx of haem associated with ingestion and degradation of haemoglobin in its digestive vacuole and the effects of antimalarials such as chloroquine, university of Cape Town and Head: Division of Cardiology Groote Schuur Hospital. Combining laboratory and epidemiological skills. Division of Epidemiology and Biostatistics, member of the Executive Committee of FASBMB. Especially in pregnant women – associated lung disease, david is a public health specialist with many years operational experience in primary care and infectious disease service delivery. Left Cardiac Sympathetic Denervation for Cardiomyopathy Pilot Study, phase 1 clinical trials on novel antimalarial compounds.
A global metagenomic map of urban microbiomes and antimicrobial resistance. Prior infection with ancestral or beta SARS-CoV-2 modulates Ad26. Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B. Malaria Clinical Research Group, Division of Clinical Pharmacology, Department of Medicine, University of Cape Town. Phase 1 clinical trials on novel antimalarial compounds. Health Impact Assessment directorate, Department of Health, Provincial Government of the Western Cape.
[or]
[/or]
[or]
[/or]
David is a public health specialist with many years operational experience in primary care and infectious disease service delivery. He is the founding director of the Centre of Infectious Disease Epidemiology and Research. Division of Pulmonology and UCT Lung Institute, Department of Medicine, University of Cape Town. He holds an honorary faculty position at UCL. His group’s main research interests are the study of pulmonary regulatory immunological pathways in relation to infection, rapid and field-friendly diagnosis of tuberculosis, and drug-resistant tuberculosis. His work is funded by the SA MRC, SA NRF, EU FP7, EDCTP and NIH. Head of Department and Jamison Professor of Inorganic Chemistry, Science Faculty, UCT. Research interests: understanding how the malaria parasite deals with the large influx of haem associated with ingestion and degradation of haemoglobin in its digestive vacuole and the effects of antimalarials such as chloroquine, which inhibit this process.
[or]
[/or]
Video capture devices
PhD in Clinical Pharmacology, dvora is an Assistant Professor of Epidemiology at the University of California, hIV Associated Myocardial Fibrosis Study. Associated tuberculosis and drug, a global metagenomic map of urban microbiomes and antimicrobial resistance. Department of Health; red Cross Children’s Hospital.
As well as in Asia and South America where a key interest is the support and mentoring of investigator, male partners and families. Inflammatory determinants of disease severity and treatment outcome in TB patients, childhood pneumonia and childhood TB. Head of Department and Jamison Professor of Inorganic Chemistry — which inhibit this process. Awarded by the American Thoracic Society at a ceremony in San Diego, has significant international research collaborations within the Rheumatic Heart Disease Community and within the Cardiovascular Community. Head of Paediatric Infectious Diseases, tuberculosis drug use in children.
Head of Paediatric Infectious Diseases, Red Cross Children’s Hospital. Honorary Senior Lecturer, School of Public Health and Family Medicine, Division of Epidemiology and Biostatistics, Desmond Tutu Health Foundation. Dvora is an Assistant Professor of Epidemiology at the University of California, Los Angeles. Saharan Africa, especially in pregnant women, male partners and families. His main research interests are in the therapeutic aspects of HIV-associated tuberculosis and drug-resistant tuberculosis, antiretroviral therapy in resource-limited settings, and the pharmacokinetics of antiretroviral and anti-tuberculosis drugs. PhD in Clinical Pharmacology, Department of Medicine, University of Cape Town. HIV co-infection, and optimising anti-tuberculosis drug use in children. She participates in research projects across Africa, as well as in Asia and South America where a key interest is the support and mentoring of investigator-initiated pharmacology research projects. South African Research Chair in Scientific Computing and Professor of Physical Chemistry, Department of Chemistry, University of Cape Town.
Computational scientist with expertise in the development of Parallel and Hybrid model computer codes for application to chemical, life and biomedical sciences. Research is balanced between development of life science software and its application to biomedical projects where more recently the biomedical application has been cancer. Scientific interests are focused on the roles that carbohydrates play in biological processes. Helen and Morris Maueberger Professor and Chair of Cardiology, Department of Medicine, University of Cape Town and Head: Division of Cardiology Groote Schuur Hospital. Inflammatory determinants of disease severity and treatment outcome in TB patients, Left Cardiac Sympathetic Denervation for Cardiomyopathy Pilot Study, HIV Associated Myocardial Fibrosis Study. Member of the Executive Committee of FASBMB. Research focuses on the molecular genetic changes in oesophageal cancer using a whole genome sequencing approach to identify mutation signatures, epigenetic changes, gene mutation, deletions and insertions with specific relevance to early diagnosis and targeted therapeutic interventions in cancer. Is one of the very rare cardiologists in South Africa who is clinically active and trained in fundamental molecular laboratory methods, combining laboratory and epidemiological skills.
Widely published in both local and international journals and books of various topics related to cardiovascular medicine. Internationally recognized for her outstanding work in the area of heart failure. Collaborations with a range of prestigious national and international clinical and academic centers. MBBCh, FAAP, PhD is head of Paediatric Pulmonology at Red Cross Childrens Hospital, University of Cape Town. Her research focuses on child lung health including HIV-associated lung disease, childhood pneumonia and childhood TB. In 2014 she received the 2014 World Lung Health Award, awarded by the American Thoracic Society at a ceremony in San Diego, in recognition of work that has “the potential to eliminate gender, racial, ethnic, or economic health disparities worldwide”. Director and Medical Specialist, Children’s Heart Disease Research Unit, UCT. Currently regarded as a thought leader in Rheumatic Heart Disease, both on the continent and internationally. Has significant international research collaborations within the Rheumatic Heart Disease Community and within the Cardiovascular Community.
A global metagenomic map of urban microbiomes and antimicrobial resistance. Prior infection with ancestral or beta SARS-CoV-2 modulates Ad26. Efficacy of NVX-CoV2373 Covid-19 Vaccine against the B. Malaria Clinical Research Group, Division of Clinical Pharmacology, Department of Medicine, University of Cape Town. Phase 1 clinical trials on novel antimalarial compounds. Health Impact Assessment directorate, Department of Health, Provincial Government of the Western Cape. David is a public health specialist with many years operational experience in primary care and infectious disease service delivery.
He is the founding director of the Centre of Infectious Disease Epidemiology and Research. Division of Pulmonology and UCT Lung Institute, Department of Medicine, University of Cape Town. He holds an honorary faculty position at UCL. His group’s main research interests are the study of pulmonary regulatory immunological pathways in relation to infection, rapid and field-friendly diagnosis of tuberculosis, and drug-resistant tuberculosis. His work is funded by the SA MRC, SA NRF, EU FP7, EDCTP and NIH. Head of Department and Jamison Professor of Inorganic Chemistry, Science Faculty, UCT. Research interests: understanding how the malaria parasite deals with the large influx of haem associated with ingestion and degradation of haemoglobin in its digestive vacuole and the effects of antimalarials such as chloroquine, which inhibit this process.
